Lung Cancer Clinical Trial

Digitally Enhanced Smoking Cessation for High Risk Smokers

Summary

This is a research study, is testing a program to improve lung health through smoking cessation and providing education around lung screening.

In this research study involves Studying the Enhanced Smoking Cessation Approaches to Promote Empowerment (ESCAPE) program compared to usual care.

The ESCAPE program was developed help women with HIV quit smoking. Women in the ESCAPE program quit smoking and stayed quit for longer (up to 3 months). For this study, investigators have added a lung screening to the ESCAPE program and want to test if this will improve lung health through increasing quit rates and lung screening.

.

View Full Description

Full Description

This is a research study, is testing a program to improve lung health through smoking cessation and providing education around lung screening. The research study procedures include: screening for eligibility and study interventions including participation in counseling and completion of questionnaires by e-mail, phone or in-person.

This research study involves participating in either the Enhanced Smoking Cessation Approaches to Promote Empowerment (ESCAPE) program or the usual care. Participants will be randomized into one of two groups:

ESCAPE: The ESCAPE program provides 8 counseling sessions over the phone, provides nicotine replacement therapy at no cost, and education about lung screening
Usual Care: The usual care program will include 1 counseling session, nicotine replacement therapy at no cost referral and enrollment in quitworks
Participants will be in this research study for up to 6-months.
It is expected that about 250 people will take part in this research study.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

55 to 77 years of age
No previous history of lung cancer
ECOG performance status < 2
≥ 30 pack year smoking history
Smoke ≥ 5 cigarettes/day
Own a mobile phone with access to a video call application
Has a primary care provider (PCP)
Provide contact information for the PCP
Active health insurance
Has not had LDCT screening
English speaking
Can complete an interview

Exclusion Criteria:

Hospitalization for severe mental illness within the last year.

The following special populations will not be included

Adults unable to consent
Individuals who are not yet adults (infants, children, teenagers)
Pregnant women
Prisoners

Study is for people with:

Lung Cancer

Estimated Enrollment:

153

Study ID:

NCT04691297

Recruitment Status:

Active, not recruiting

Sponsor:

Dana-Farber Cancer Institute

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Brigham and Women's Hospital
Boston Massachusetts, 02115, United States
Dana Farber Cancer Institute
Boston Massachusetts, 02115, United States

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Estimated Enrollment:

153

Study ID:

NCT04691297

Recruitment Status:

Active, not recruiting

Sponsor:


Dana-Farber Cancer Institute

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider